The Federal Trade Commission has accused several drugmakers of violating antitrust laws, via agreements the commission said delayed the U.S. launches of cheaper generic versions of two popular pain treatments.
Mar 31, 2016
0
1
The same strategy that Martin Shkreli used to get away with a 5,000-percent price increase on an old drug is used by many other drugmakers to maintain sky-high prices on billions of dollars' worth of medications.
Mar 3, 2016
0
0
(HealthDay)—Pennsylvania physicians have called for state- and national-level medical associations to take an active role in addressing the issue of increasing generic drug prices, according to an article published by the ...
Feb 12, 2016
0
1
While approved generics are required to be equivalent to their brand-named counterparts in terms of active ingredients, some may wonder if a switch between generics could cause problems for someone who relies on daily medication ...
Feb 11, 2016
0
42
US pharmaceutical giant Mylan said Wednesday it has struck a $9.9 billon deal to buy Meda, capping two years of dogged pursuit of the Swedish drugmaker.
Feb 11, 2016
0
4
British pharmaceuticals giant AstraZeneca on Thursday said its net profits more than doubled in 2015, adding it expects lower sales this year on US patent expiry of cholesterol treatment Crestor.
Feb 4, 2016
0
0
An article published online today in Blood, the Journal of the American Society of Hematology (ASH), suggests that pharmaceutical companies use several strategies to keep affordable generic drugs from the market, illustrating ...
Jan 27, 2016
0
2
All clinicians should prescribe generic medications whenever possible as a way to improve adherence to therapy and clinical outcomes while containing costs, the American College of Physicians (ACP) advises in a new paper ...
Nov 23, 2015
0
24
As criticism of soaring prescription drug prices in the U.S. grows, global spending on medicines is expected to rise 3 percent to 6 percent annually for the next five years, according to a new forecast from IMS Health.
Nov 18, 2015
0
10
(HealthDay)—Brand-name drugs may offer more value, but not in the way you'd expect, a new study from New Zealand suggests.
Nov 5, 2015
0
22
